How High Will Brown Forman Stock Go?
On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…
Sell
44
CIB Quote, Financials, Valuation and Earnings
Last price:
$45.82
Seasonality move
:
-2.49%
Day range:
$45.78 - $46.62
52-week range:
$30.25 - $46.81
Dividend yield:
13.49%
P/E ratio:
7.15x
P/S ratio:
1.41x
P/B ratio:
1.12x
Volume:
208.5K
Avg. volume:
297.5K
1-year change:
38.36%
Market cap:
$11B
Revenue:
$6.9B
EPS (TTM):
$6.42
Analysts' Opinion
-
Consensus RatingGrupo Cibest SA has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $39.77, Grupo Cibest SA has an estimated downside of -13.46% from its current price of $45.95.
-
Price Target UpsideAccording to analysts, the highest upside price target is $55.00 representing 19.7% upside increase from its current price of $45.95.
Fair Value
-
According to the consensus of 6 analysts, Grupo Cibest SA has -13.46% downside to fair value with a price target of $39.77 per share.
CIB vs. S&P 500
-
Over the past 5 trading days, Grupo Cibest SA has overperformed the S&P 500 by 3.28% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Grupo Cibest SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Grupo Cibest SA revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Grupo Cibest SA reported revenues of $1.7B.
Earnings Growth
-
Grupo Cibest SA earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Grupo Cibest SA reported earnings per share of $1.75.
Enterprise value:
9.5B
EV / Invested capital:
--
Price / LTM sales:
1.41x
EV / EBIT:
1.69x
EV / Revenue:
1.39x
PEG ratio (5yr expected):
2.09x
EV / Free cash flow:
3.62x
Price / Operating cash flow:
3.69x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.78%
Net Income Margin (TTM):
22.37%
Return On Equity:
15.42%
Return On Invested Capital:
9.31%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $5.9B | $6.8B | $6.9B | $1.7B | $1.7B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $6.38 | $6.21 | $6.42 | $1.79 | $1.75 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.4B | $7.8B | $6.9B | $16.5B | $15.1B | |
| Total Assets | $69B | $77.8B | $75.1B | $88.3B | $88.1B | |
| Current Liabilities | $571.2M | $737M | $337M | $2.9B | $2.6B | |
| Total Liabilities | $61.1B | $69.3B | $67B | $78.5B | $78B | |
| Total Equity | $7.8B | $8.5B | $8.1B | $9.8B | $10.1B | |
| Total Debt | $7.9B | $8.1B | $8.2B | $7.5B | $5.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $1.8B | $3.1B | -$2.9B | $103.7M | |
| Cash From Investing | -- | $139.3M | -$207.4M | $50.8M | -$18.7M | |
| Cash From Financing | -- | -$1.7B | -$2.7B | -$569.1M | -$958.7M | |
| Free Cash Flow | -- | $1.3B | $2.6B | -$3B | $36.3M | |
CIB
Sector
Market Cap
$11B
--
Price % of 52-Week High
98.16%
--
Dividend Yield
13.49%
--
Shareholder Yield
--
--
1-Year Price Total Return
38.36%
--
Beta (5-Year)
0.932
--
Dividend yield:
13.49%
Annualized payout:
$3.44
Payout ratio:
53.73%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$44.95
200-day SMA
Buy
Level
$37.98
Bollinger Bands (100)
Buy
Level
40.22 - 44.32
Chaikin Money Flow
Sell
Level
-25.3K
20-day SMA
Buy
Level
$45.01
Relative Strength Index (RSI14)
Buy
Level
60.43
ADX Line
Buy
Level
33.5
Williams %R
Neutral
Level
-28.9562
50-day SMA
Buy
Level
$43.28
MACD (12, 26)
Buy
Level
12.58
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Sell
Level
-151.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.5797)
Sell
CA Score
(Annual)
Level (-1.9034)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.8186)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.
Stock Forecast FAQ
In the current month, CIB has received 0 Buy ratings 6 Hold ratings, and 0 Sell ratings. The CIB average analyst price target in the past 3 months is $39.77.
-
Where Will Grupo Cibest SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Grupo Cibest SA share price will drop to $39.77 per share over the next 12 months.
-
What Do Analysts Say About Grupo Cibest SA?
Analysts are divided on their view about Grupo Cibest SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Grupo Cibest SA is a Sell and believe this share price will rise from its current level to $28.60.
-
What Is Grupo Cibest SA's Price Target?
The price target for Grupo Cibest SA over the next 1-year time period is forecast to be $39.77 according to 6 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is CIB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Grupo Cibest SA is a Hold. 6 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CIB?
You can purchase shares of Grupo Cibest SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Grupo Cibest SA shares.
-
What Is The Grupo Cibest SA Share Price Today?
Grupo Cibest SA was last trading at $45.82 per share. This represents the most recent stock quote for Grupo Cibest SA. Yesterday, Grupo Cibest SA closed at $45.95 per share.
-
How To Buy Grupo Cibest SA Stock Online?
In order to purchase Grupo Cibest SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
